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Introduction 
Idiopathic pulmonary haemosiderosis (IPH) is a 
rare disease of unknown aetiology. Its association 
with other diseases may be of help in establishing its 
pathogenesis. A few single case reports of IPH with 
other concurrent autoimmune diseases, have been 
reported as: autoimmune haemolytic anaemia (l), 
monoclonal gammopathy (2), rheumatoid arthritis 
(five cases) (3), thyrotoxicosis (4), and recently a case 
of systemic vasculitis (5). However, a case of idio- 
pathic pulmonary haemosiderosis and autoimmune 
hypothyroidism has never been reported. Recently, 
the calorimetric blue intensity of the cytoplasm of 
alveolar macrophages (AM) on iron stain (i.e. Perl’s 
prussian blue stain) has been proposed as an accurate 
method of quantifying the severity of pulmonary 
haemorrhage (6-7). Furthermore, the local immune 
process on the alveoli has not been studied in this 
rare entity, as well as the effects of treatment other 
than corticosteroids and gluten-free diet (8). 
Case Report 
The patient was a 20-year-old male who was 
admitted to hospital for evaluation of known IPH, 
because of his enrolment in the army. Ten years 
previously this patient had presented with recurrent, 
severe episodes of haemoptyses. Investigation 
revealed iron deficiency anaemia, and his chest 
radiograph showed diffuse alveolar shadows. Bron- 
choscopy at that time was normal, but haemosiderin- 
laden AM were found on bronchial washings. 
Autoantibody screen was negative. At that time, 
other causes of pulmonary haemorrhage were 
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excluded and a diagnosis of idiopathic pulmonary 
haemosiderosis was made. He was subsequently 
treated with a course of corticosteroids, with gradual 
remission of the disease. Ten years later, the patient 
enrolled in the army and medical examination 
revealed clinical findings consisting of anaemia, 
hypothyroidism and dermal ichthyosis. Haematology 
and serum biochemical analysis showed sideropenic 
anaemia. Indirect and direct Coombs’s tests were 
negative. Thyroid hormones were: thyroxine 2 ng 
ml-’ (normal range 50-120), triiodothyronine O-2 ng 
ml-’ (normal range 0.7-2) TSH>30.0pU ml- ’ 
(normal values 0.63.0). Anti-thyroglobulin anti- 
bodies were positive (1:400), anti-thyroid microsomal 
antibodies were positive (1:2560), but the anti- 
mitochondrial antibodies were negative. Technetium 
99 scan showed a diffusely decreased uptake by the 
thyroid gland. Serum complement C3 and C4 levels 
and results of liver function tests were normal. Lupus 
erythematosus cells, anti-nuclear antibodies and 
rheumatoid factor were negative. Anti-neutrophil 
cytoplasmic antibodies and serology for collagen 
vascular disease were negative. Serum immune 
complexes were 5 pg ml ~ ’ (normal< 1.5 rug ml - ‘). 
Gliadin and reticulin antibodies were negative. Anti- 
glomerular basement membrane antibodies were not 
found. A TRH test showed an excessive response to 
TSH. Pulmonary function tests (spirometry and lung 
volumes) showed a mild restrictive ventilatory defect, 
but the transfer factor for carbon monoxide cor- 
rected for alveolar volume (KCO) was reduced (70% 
of predicted value). Arterial blood gases and chest 
radiograph were normal. 
Fibreoptic bronchoscopy revealed a normal bron- 
chial tree, and bronchoalveolar lavage fluid (BALF) 
analysis performed in clinical remission showed 
11.4 x lo4 cells ml ~ ’ with 82% AM, 16% lympho- 
cytes and 2% neutrophils. Cytological analysis 
revealed 40% haemosiderin-laden AM. Calorimetric 
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Table I Bronchoalveolar lavage findings before and after 1 month of treatment with 
cimetidine 
AM Lym Neut T-cells CD4+:CD8+ 
Treatment Cells ml - ’ (“A) (“h, W) (%I ratio Golde index 
Before 11.4~ lo4 82 16 2 66 0.3 120 
After 9.3 x lo4 89 10 1 13 1.2 30 
AM, alveolar macrophages; Lym, Lymphocytes; Neut, neutrophils. 
blue intensity of AM cytoplasm on Pearl’s prussian 
blue stain (Golde index) was 120 (normal 5-25) (9). 
Flow cytometry lymphocyte-phenotyping of BALF 
was performed with a fluorescence activated cell 
analyser (FACS-star plus, Becton-Dickinson, San 
Jose, CA, USA) used to calculate the absolute CD4 + 
and CD8+ cells, and the CD4+:CD8 + ratio. We 
used fluorescein-conjugated monoclonal antibodies 
OKT3, OKT4, OKT8 (Ortho diagnostics, Raritan, 
NJ, U.S.A.), and Bl (Coulter Immunology, Hialeah, 
FL, U.S.A.) and found a CD4+/CDS+ ratio: 0.30 
(Table 1). Blood CD4+/CD8+ ratio was 1.32. Trans- 
bronchial biopsy showed alveolar spaces with 
haemosiderin-laden AM with moderate thickening of 
the alveolar septae and slight increase of type II cells. 
There was no evidence of vasculitis or granuloma 
formation. Using the immunofluorescence technique, 
no antibody or complement deposition was found on 
lung tissue. Sperm analysis showed findings consis- 
tent with asthenospermia. The patient was put on 
treatment with thyroxine 0.1 mg daily, and cimeti- 
dine 400 mg three times daily. His clinical condition 
in terms of anaemia, hypothyroidism and ichthyosis 
improved dramatically. Similarly, his asthenospermia 
was reversed. Repeat BALF analysis after 3 months 
of treatment showed: 9.3 x IO4 cells ml- i with 89% 
AM, 10% lymphocytes and 1% neutrophils. Cytologi- 
cal analysis revealed 10% haemosiderin-laden AM. 
Calorimetric blue intensity of AM cytoplasm (Golde 
index) was 30. Immunocytology of BALF showed a 
CD4+/CD8+ ratio: 1.3 (Table 1). Blood CD4+/ 
CD8+ ratio was 1.52. After 5 years follow-up, there 
has been no recurrence of symptoms and the patient 
is symptom-free. 
Discussion 
This case fulfils the criteria for the diagnosis of 
IPH, since the patient had recurrent pulmonary 
haemorrhage in the absence of other explanatory 
conditions, such as infection, heart or systemic dis- 
ease as Goodpasture’s syndrome, Wegener’s disease, 
or collagen vascular disease. The course of the 
disease was also consistent with the diagnosis of 
IPH, since it presented with repeated relapses and 
remissions over a period of more than 10 yr. In 
addition, consistent with the diagnosis of IPH was 
the histologic examination of the transbronchial lung 
biopsy specimen of our patient. 
Autoimmune hypothyroidism was also well- 
documented in the patient, since despite the 
decreased thyroid hormones, the excess response to 
TRH test, and the decreased Technetium 99 up- 
take by the thyroid gland, the anti-thyroid micro- 
somial antibodies and thyroglobulin antibodies were 
positive. 
The aetiology of the disease remains unknown, but 
autoimmunity is strongly suspected (4). However, the 
autoimmune hypothesis has not been proved. No 
consistent immunological abnormality has been 
reported, and on lung biopsies no immunoglobulins, 
immune complexes or complement depositions are 
found. 
This case is the first in the literature to describe 
such a rare combination of diseases, and outlines the 
possibility of a common pathogenetic mechanism 
between IPH and other autoimmune diseases. Previ- 
ous reports suggest a link between IPH and a variety 
of other autoimmune diseases (l-58). 
The patient presented with severe autoimmune 
hypothyroidism and asthenospermia. On treatment 
with thyroxine for his hypothyroidism and cimetidine 
for its possible immunoregulatory effects on the 
CD8 + T-lymphocytes, all the underlying diseases 
were ameliorated. The severe dermal ichthyosis was 
also cleared. 
Several investigators (10-12) have described 
studies showing that histamine type 2 receptor 
antagonists, such as cimetidine, prevent the suppres- 
sion of lymphocyte effector function by histamine. 
Direct inactivation of suppressor T-cells may account 
for this phenomenon, or it may be that the produc- 
tion of a histamine-induced suppressor factor is 
inhibited (11). Our findings suggest that cimetidine 
reduces the number of suppressor T-cells in vivo, 
thereby causing a reduction in functional suppressor 
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activity. This finding may have clinical implications 
changing our approach to this disease, since the 
best treatment is not yet known, due to lack of 
prospective controlled studies of such a rare disease 
with a variable course. 
Immunocytologic analysis of BALF by flow 
cytometry showed a suppressor/cytotoxic profile of 
T-lymphocytes with a normal CD4+lCD8 + ratio in 
blood. These observations are of interest since they 
confirm our previous observations (8), and suggest 
that the BALF findings may be a response to local 
presence of an unknown antigen. A relationship of 
immunoregulation to disease activity is suggested. 
Conceivably, disease activity may be mediated by 
suppressor T-cells, since the CD4+/CD8+ ratio 
increased from 0.3 before treatment, to 1.3 after 
treatment. This change suggests that the relative 
amount of CDS+ lymphocytes decreased in lung 
alveoli, when the patient was under treatment and 
presumably improved. Similarly, the Golde index 
reduced from 120 to 30 suggesting that occult pul- 
monary haemorrhage decreased after treatment. 
These findings give new insights into pathogenesis of 
the disease, and call for prospective multicentre trials 
for new modes of treatment including cimetidine. The 
relation of the local suppression to disease activity 
has also to be investigated. Furthermore, BALF 
analysis may be used as a simple and valuable 
technique for follow-up of these patients. 
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